Skip to content

Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema

Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06188858
Enrollment
267
Registered
2024-01-03
Start date
2020-01-01
Completion date
2023-12-01
Last updated
2024-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Brief summary

Our aim was to identify optimal incision sites for LVA in extremity lymphedema that would result in the most effective drainage effect for reducing limb edema and enhancing patients' quality of life.

Detailed description

designing the optimal incision sites and identifying functional lymphatic vessels imaging is crucial for success, primarily due to its efficacy in draining edematous lymphatic fluid and reducing swelling in patients with lymphedema. In this study, we conducted patients with LVA lymphedema to investigate the correlation between LVA incision design, intraoperative functional lymphatic vessel assessment, postoperative limb reduction, and patient satisfaction. question 1:Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity lymphedema

Interventions

None listed

Sponsors

Taizhou Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

Aged 18-80 years; Lymphedema and swelling of the limbs for more than 3 months \-

Exclusion criteria

* lipedema;myoedema

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with lymphedema stagethrough study completion, an average of 4 yearstage 0-3
Number of Optimal Incision Site Designthrough study completion, an average of 4 yearOptimal Incision Site Design for Lymphaticovenular Anastomosis
Rate of lymphatic vessel Functional Parametersthrough study completion, an average of 4 yearintraoperative functional lymphatic vessel assessment
Circumferential Reduction ratethrough study completion, an average of 4 yearpostoperative limb reduction and patient satisfaction

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026